Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
4ckr | DI1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 1.000 | |
4at4 | T6E | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.497 | |
1fdw | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.481 | |
2ofv | 242 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.479 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.478 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.468 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.467 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.464 | |
2bu9 | HFV | Isopenicillin N synthase | 1.21.3.1 | 0.463 | |
2jdd | ACO | Probable acetyltransferase | / | 0.459 | |
3njo | P2M | Abscisic acid receptor PYR1 | / | 0.454 | |
3p2o | NAD | Bifunctional protein FolD | / | 0.454 | |
2fm5 | M99 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
4bii | PYW | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
2gjl | FMN | Nitronate monooxygenase | 1.13.12.16 | 0.451 | |
4dbz | NDP | Putative ketoacyl reductase | 1.3.1 | 0.451 | |
1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
4wo5 | 324 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.450 | |
3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.449 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.449 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.449 | |
4a83 | DXC | Major pollen allergen Bet v 1-A | / | 0.449 | |
1xu7 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.448 | |
2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.448 | |
1szm | BI4 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.447 | |
4oew | 5IO | cGMP-specific 3',5'-cyclic phosphodiesterase | / | 0.447 | |
5irn | ADP | Nucleotide binding oligomerization domain containing 2 | / | 0.447 | |
1fds | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.446 | |
1pq9 | 44B | Oxysterols receptor LXR-beta | / | 0.446 | |
2ntj | P1H | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.446 | |
2y6f | M9F | Isopenicillin N synthase | 1.21.3.1 | 0.446 | |
2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.445 | |
2bxo | OPB | Serum albumin | / | 0.442 | |
3bw4 | FMN | Putative 2-nitropropane dioxygenase | / | 0.442 | |
3qri | 919 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.442 | |
4iah | 1DX | Alr2278 protein | / | 0.442 | |
4phl | PIL | Phosphodiesterase | / | 0.442 | |
5g53 | NEC | Adenosine receptor A2a | / | 0.442 | |
1uzw | CDH | Isopenicillin N synthase | 1.21.3.1 | 0.441 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.441 | |
3a1l | 2CC | Cytochrome P450 | / | 0.441 | |
4bb5 | HD2 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.441 | |
5cpb | NAD | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 |